Clinical Trials Directory

Trials / Completed

CompletedNCT00913224

To Demonstrate the Relative Bioavailability of Diclofenac Sodium 50 mg Enteric-Coated Tablets

A Relative Bioavailability Study of Diclofenac Sodium 50 mg Enteric-Coated Tablets

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
38 (actual)
Sponsor
Sandoz · Industry
Sex
Male
Age
18 Years – 41 Years
Healthy volunteers
Accepted

Summary

To demonstrate the relative bioavailability of Diclofenac Sodium 50 mg enteric-coated tablets.

Conditions

Interventions

TypeNameDescription
DRUGDiclofenac Sodium 50 mg Tablets (Geneva Pharmaceuticals, Inc)
DRUGVoltaren 50 mg Tablets (Geigy Pharmaceuticals)

Timeline

Start date
1993-04-01
Primary completion
1993-04-01
Completion
1993-04-01
First posted
2009-06-04
Last updated
2017-03-28

Source: ClinicalTrials.gov record NCT00913224. Inclusion in this directory is not an endorsement.